Checking for Markers of Bone Turnover

Dr Paul Glendenning

writer

Dr Paul Glendenning

Dr Paul Glendenning

Markers of bone turnover, measured in blood or urine, correlate with changes in the metabolic activity of bone.

The rate of bone remodelling is important. With ageing, the quantum of bone removed/ resorbed and the amount replaced/ formed becomes increasingly imbalanced. Consequently, the more bone remodelling units that are active at any one time, or the greater the activity of individual units, the greater the overall rate of bone loss.

Bone turnover markers are probably predictive of the rate of bone loss and could help determine the efficacy of treatment.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Scientia Prof Kaarin Anstey

Scientia Prof Kaarin Anstey

New Brain Health Guidelines – What GPs Can Do

Expert panel – Dr Georgia Rigas & Dr Nadia Tejani, facilitated by Dr Angela Kwong

Expert panel – Dr Georgia Rigas & Dr Nadia Tejani, facilitated by Dr Angela Kwong

Navigating Perimenopause and Menopause – Managing Weight, Health and Wellbeing in General Practice

A/Prof Daryl Efron

A/Prof Daryl Efron

Autism & Mental Health Comorbidities

Dr Rebecca Purvis

Dr Rebecca Purvis

Pharmacogenomics in General Practice

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.